EDITAS MEDICINE, INC.: current liabilities
Current liabilities for EDITAS MEDICINE, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All EDITAS MEDICINE, INC. financial histories
What this measure means
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
Exact concept: us-gaap:LiabilitiesCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2015-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 46,246,000 | USD | 2026-03-09 | 10-K · 0001650664-26-000017 |
| At date | 2024-12-31 | 77,225,000 | USD | 2026-03-09 | 10-K · 0001650664-26-000017 |
| At date | 2023-12-31 | 63,217,000 | USD | 2025-03-05 | 10-K · 0001650664-25-000022 |
| At date | 2022-12-31 | 60,110,000 | USD | 2024-02-28 | 10-K · 0001650664-24-000008 |
| At date | 2021-12-31 | 46,884,000 | USD | 2023-02-22 | 10-K · 0001558370-23-001764 |
| At date | 2020-12-31 | 58,208,000 | USD | 2022-02-24 | 10-K · 0001558370-22-001950 |
| At date | 2019-12-31 | 59,963,000 | USD | 2021-02-26 | 10-K · 0001558370-21-001915 |
| At date | 2018-12-31 | 35,900,000 | USD | 2020-02-26 | 10-K · 0001558370-20-001476 |
| At date | 2017-12-31 | 36,707,000 | USD | 2019-03-01 | 10-K · 0001558370-19-001364 |
| At date | 2016-12-31 | 33,083,000 | USD | 2018-03-08 | 10-K · 0001558370-18-001721 |
| At date | 2015-12-31 | 6,925,000 | USD | 2017-03-03 | 10-K · 0001558370-17-001340 |
Related financial histories
- EDITAS MEDICINE, INC.: total assets
- EDITAS MEDICINE, INC.: total liabilities
- EDITAS MEDICINE, INC.: stockholders equity
- EDITAS MEDICINE, INC.: cash and cash equivalents
- EDITAS MEDICINE, INC.: net income or loss
- EDITAS MEDICINE, INC.: operating cash flow
- EDITAS MEDICINE, INC.: capital expenditure payments
- EDITAS MEDICINE, INC.: revenue
- EDITAS MEDICINE, INC.: contract revenue excluding tax
- EDITAS MEDICINE, INC.: financing cash flow
- EDITAS MEDICINE, INC.: investing cash flow
- EDITAS MEDICINE, INC.: retained earnings or deficit
- EDITAS MEDICINE, INC.: basic weighted-average shares
- EDITAS MEDICINE, INC.: diluted weighted-average shares
- EDITAS MEDICINE, INC.: basic earnings per share
- EDITAS MEDICINE, INC.: diluted earnings per share
- EDITAS MEDICINE, INC.: net property, plant and equipment
- EDITAS MEDICINE, INC.: share-based compensation expense
- EDITAS MEDICINE, INC.: operating income or loss
- EDITAS MEDICINE, INC.: current assets
- EDITAS MEDICINE, INC.: current accounts payable
- EDITAS MEDICINE, INC.: operating expenses
- EDITAS MEDICINE, INC.: research and development expense
Inspect the source
- Entity
- EDITAS MEDICINE, INC. / CIK 0001650664
- Captured
- 2026-09-21T17:21:54.063Z
- SEC response SHA-256
67c484f3395e87e1bb6f7518c2b21f82c8794702db1015a8bdc9cdad58ba5253
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001650664.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))